8-47858852-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM2BP4_StrongBP6_Very_StrongBP7
The NM_006904.7(PRKDC):āc.6342A>Gā(p.Glu2114=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00107 in 1,613,038 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.00072 ( 0 hom., cov: 33)
Exomes š: 0.0011 ( 1 hom. )
Consequence
PRKDC
NM_006904.7 synonymous
NM_006904.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.438
Genes affected
PRKDC (HGNC:9413): (protein kinase, DNA-activated, catalytic subunit) This gene encodes the catalytic subunit of the DNA-dependent protein kinase (DNA-PK). It functions with the Ku70/Ku80 heterodimer protein in DNA double strand break repair and recombination. The protein encoded is a member of the PI3/PI4-kinase family.[provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 8-47858852-T-C is Benign according to our data. Variant chr8-47858852-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 542034.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.438 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRKDC | NM_006904.7 | c.6342A>G | p.Glu2114= | synonymous_variant | 47/86 | ENST00000314191.7 | |
PRKDC | NM_001081640.2 | c.6342A>G | p.Glu2114= | synonymous_variant | 47/85 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRKDC | ENST00000314191.7 | c.6342A>G | p.Glu2114= | synonymous_variant | 47/86 | 1 | NM_006904.7 | P1 | |
PRKDC | ENST00000338368.7 | c.6342A>G | p.Glu2114= | synonymous_variant | 47/85 | 1 | |||
PRKDC | ENST00000697609.1 | n.503A>G | non_coding_transcript_exon_variant | 1/4 | |||||
PRKDC | ENST00000697610.1 | n.143A>G | non_coding_transcript_exon_variant | 2/4 |
Frequencies
GnomAD3 genomes AF: 0.000717 AC: 109AN: 152062Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
109
AN:
152062
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000692 AC: 172AN: 248404Hom.: 0 AF XY: 0.000853 AC XY: 115AN XY: 134748
GnomAD3 exomes
AF:
AC:
172
AN:
248404
Hom.:
AF XY:
AC XY:
115
AN XY:
134748
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00111 AC: 1620AN: 1460858Hom.: 1 Cov.: 31 AF XY: 0.00114 AC XY: 828AN XY: 726584
GnomAD4 exome
AF:
AC:
1620
AN:
1460858
Hom.:
Cov.:
31
AF XY:
AC XY:
828
AN XY:
726584
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000716 AC: 109AN: 152180Hom.: 0 Cov.: 33 AF XY: 0.000699 AC XY: 52AN XY: 74364
GnomAD4 genome
AF:
AC:
109
AN:
152180
Hom.:
Cov.:
33
AF XY:
AC XY:
52
AN XY:
74364
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2022 | PRKDC: BP4, BP7 - |
Severe combined immunodeficiency due to DNA-PKcs deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at